WW 41 (Digoxin 250 mcg (0.25 mg))
Pill imprint WW 41 has been identified as Digoxin 250 mcg (0.25 mg).
Digoxin is used in the treatment of atrial fibrillation; heart failure and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy. Digoxin 250 mcg (0.25 mg) is not subject to the Controlled Substances Act.
See also related documents.
Images for WW 41 (Digoxin 250 mcg (0.25 mg))
- 250 mcg (0.25 mg)
- 7.00 mm
- Prescription only
- Drug Class:
- Group V antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
|NDC Code||Manufacturer / Repackager|
|51079-0848||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about digoxin
- Digoxin solution
- Digoxin tablets
- Digoxin (Advanced Reading)
- Digoxin Intravenous (Advanced Reading)